BSE filing, NSE: ADIRASA. Summary written from the filing by ALFA Finder's alert engine.
Genpharmasec Ltd: key numbers
- Share price
- ₹0.99
- Market cap
- ₹54.82 Cr
- Revenue (annual)
- ₹139.9 Cr
- Net profit (annual)
- ₹1.60 Cr
- P/E (TTM)
- -450.0×Sector 46.1×
- Promoter holding
- 32.06%+2.08% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Genpharmasec Ltd
All →Genpharmasec Board Meeting Date
Genpharmasec Ltd will hold a Board meeting on 03 Nov 2026. Agenda includes proposing approval of Q2/H1 FY27 unaudited results.
Genpharmasec Other Announcement
Genpharmasec Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing provides a standard breakdown of promoter and public shareholding.
Genpharmasec Annual General Meeting
Genpharmasec Limited conducted its 34th Annual General Meeting on September 29, 2026. Shareholders considered resolutions including the adoption of FY26 financial statements and director re-appointments.
Genpharmasec Annual Report
Genpharmasec Ltd filed its 34th Annual Report for FY 2025-26 with BSE, including the AGM notice for 29 September 2026. The report covers audited financials, board updates, and governance disclosures.
Genpharmasec Management Change
Genpharmasec Limited has re-appointed Sohan Chaturvedi as Executive Director for a 36-month term effective April 26, 2027. This change is approved by the Board.
Genpharmasec Annual General Meeting
Genpharmasec Limited has announced the closure of its share transfer books from September 23 to 29, 2026, for the 34th Annual General Meeting.
Other board meeting date announcements
All →Nisus Finance Services Co Board Meeting Date
Nisus Finance has scheduled a board meeting for 13 November 2026 to consider unaudited Q2 and half-year results. The trading window stays closed until 48 hours after the results.
Empower India Board Meeting Date
Empower India Ltd intimated BSE of a 03 November 2026 board meeting to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. Trading window closed from 01 October 2026 until 48 hours after results.
Supertex Industries Board Meeting Date
Supertex Industries will hold a board meeting on 5 November 2026 to consider unaudited Q2 FY27 results. The trading window stays closed until 7 November 2026.
HPL Electric & Power Board Meeting Date
HPL Electric & Power will hold a board meeting on November 5, 2026 to consider quarterly results. The trading window remains closed until 48 hours after results.
Belding India Board Meeting Date
Belding India will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. This is prior intimation of the meeting.
Elnet Technologies Board Meeting Date
Elnet Technologies Limited has given prior intimation of its 207th board meeting on 06 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The meeting has not yet been held.